NACI literature review on the effects of palivizumab prophylaxis on reducing the complications associated with respiratory syncytial virus in infants.: HP40-321/2022E-PDF
"The literature review examined the evidence on the effectiveness of palivizumab (PVZ) prophylaxis compared to the administration of placebo or to no prophylaxis in reducing the complications associated with RSV infection in children. The outcomes of interest included hospitalization, length of hospital stay, stay in intensive care, length of stay (LOS) in intensive care, use of oxygen therapy, length of oxygen therapy use, use of mechanical ventilation (MV), length of MV use, long-term sequelae (e.g., wheezing, asthma), and mortality"--Executive summary, page 6.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.914234&sl=0
| Department/Agency |
|
|---|---|
| Title | NACI literature review on the effects of palivizumab prophylaxis on reducing the complications associated with respiratory syncytial virus in infants. |
| Variant title |
|
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Digital text |
| Electronic document | |
| Note(s) |
|
| Publishing information |
|
| Description | 1 online resource (133 pages) |
| ISBN | 9780660449388 |
| Catalogue number |
|
| Departmental catalogue number | 220363 |
| Subject terms |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: